Science
Mechanism of Action
Ephedra Sinica Extract influences key skin processes by inhibiting tyrosinase activity and reducing melanin production at the gene expression level, contributing to a visible brightening effect. It also actively suppresses inflammatory responses and photoaging by downregulating UVB-induced cyclooxygenase (COX)-2 and matrix metalloproteinase (MMP)-1 expression through the Raf/MEK1/2/ERK1/2 phosphorylation pathway. Furthermore, its inherent antibacterial properties support skin health and aid in healing, alongside its recognized role as a skin conditioning and tonic agent.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 In an in vitro study, a 50 ㎍/mL concentration decreased tyrosinase activity by 70.4% and melanin generation by 64% in SK-MEL-2 melanoma cells, suggesting potent skin whitening potential.
- 02 Research on immortalized human keratinocytes (HaCaT cells) revealed its capacity to significantly suppress UVB-induced COX-2 and MMP-1 expression, alongside downregulating Raf/MEK1/2/ERK1/2 phosphorylation, demonstrating anti-inflammatory and anti-photoaging effects.
- 03 A clinical study on the topical application of Ephedra sinica's *root* extract (distinct from the whole plant extract) showed partial effectiveness in improving skin furrows, specifically reducing average and maximum roughness, in subjects under 50 after 8 weeks.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
While no specific optimal pH range for the stability of Ephedra Sinica Extract in cosmetic formulations has been identified, historical data suggests an alkaline pH between 12 and 13 was considered appropriate for ephedrine extraction. The extract demonstrates versatility, having been successfully prepared using both distilled water and ethanol, and incorporated into oil-based (e.g., oleic acid) and water-based (e.g., Carbopol gel) formulations.
Safety
Safety Profile
The U.S. FDA banned dietary supplements containing ephedrine alkaloids, a stimulant found in Ephedra sinica, in 2004 due to serious systemic health risks. It is critical to note that Ephedra extracts *devoid of ephedrine alkaloids* are not subject to this ban and remain legally available for cosmetic use. There is currently no dedicated safety assessment for 'EPHEDRA SINICA EXTRACT' for cosmetic use from either the Cosmetic Ingredient Review (CIR) or the Scientific Committee on Consumer Safety (SCCS), indicating a gap in specific cosmetic safety data.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While exhibiting promising in-vitro efficacy for brightening, anti-inflammatory, and anti-photoaging effects, the lack of specific cosmetic safety assessments by CIR or SCCS, coupled with the historical FDA ban on ephedrine alkaloids in supplements, indicates insufficient data for a confident recommendation in precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…